CClinicalTrials.gg
CompletedNCT05298839Atılım UnvUpdated Apr 6, 2022

Effect of COVID-19 Infection on the Performance of Adolescent Professional Overhead Athletes

An observational study in COVID-19 and Sport Performance, Professional Overhead Athletes, sponsored by Atılım University. Completed at 1 site in Turkey. Open to participants aged 12 Years to 20 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-04-06.

Sponsored by Atılım University · Observational

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
47
Ages
12 Years to 20 Years
Sex
All
01

Study summary

COVID-19 is known to also cause damage outside the pulmonary system, particularly the cardiovascular and the musculoskeletal system. The studies on the effects of COVID-19 infection on different populations may provide valuable information for health professionals. Derangements in the cardiorespiratory and musculoskeletal systems which normally direct effect on the sports performance of athlete together with physical inactivity during COVID-19 infection are the main factors that may decrease the performance of the professional athletes. Although it may be well anticipated that COVID-19 will reduce sports performance; there are scarce studies in the literature. The aim of this study is to compare the sports performance of adolescent athletes that has COVID-19 infection with those did not.

Read the detailed description

Extensor muscle endurance, flexor muscle endurance and the lateral core muscle endurance were evaluated. All tests were performed by a chronometer and test was terminated as the position was lost and the time passed was recorded. Hand grip strength was measured by Jamar hand dynamometer. Health ball throwing test was used to evaluate upper extremity open kinetic chain and explosive power. Pro-agility test was used to evaluate the agility. Step test was performed for 3 minutes with a 30 cm high step board.

02

Conditions studied

  • COVID-19
  • Sport Performance, Professional Overhead Athletes

Browse trials for

Keywords

  • COVID-19
  • sport performance
  • adolescent athletes
  • overhead sport
03

In context

COVID-19

7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.

This study's enrollment of 47 is below the median of 261 across 3,136 observational studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

Atılım University is the lead sponsor of 35 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 20 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Professional athletes

Inclusion criteria

  • Basketball, volleyball, handball, tennis and American football players
  • Between 12 to 20
  • Performing sports-specific training more than two times a week at least for 1 year

Exclusion criteria

Exclusion Criteria:

  • Vertebral, upper or lower extremity injury within the last 6 weeks or had undergone a surgery
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
47 participants (actual)
Patient registry
No

Groups and cohorts

  • COVID-19

    Diagnostic Test: Evaluation of core muscle endurance, hand grip strength, upper extremity functional performance, reaction time, agility performance and 3 minutes step test

  • Non COVID-19

    Diagnostic Test: Evaluation of core muscle endurance, hand grip strength, upper extremity functional performance, reaction time, agility performance and 3 minutes step test

Interventions

  • Diagnostic testEvaluation of core muscle endurance, hand grip strength, upper extremity functional performance, reaction time, agility performance and 3 minutes step test

    Core muscle endurance was evaluated with extensor muscle endurance test, flexor muscle endurance test and lateral muscle endurance test. Hand Grip Strength was evaluated with Jamar hand dynamometer. Upper extremity functional performance was evaluated with health ball throwing test. Reaction time was evaluated with Fitlight Trainer. Agility performance was evaluated with Pro-agility test. Cardiovascular endurance was evaluated with the 3-minute step test.

06

What researchers measure

Primary outcomes

  1. Core Muscle Endurance

    Four different tests were used to evaluate core stabilization. Sorensen test was performed for extensor muscle endurance. For the Sorensen test, young athletes were laid supine in a fixed bed of 76 cm height and 61 cm width; and asked to extend their body over the pelvis and keep the position as long as they could. Core flexor muscle endurance was measured in the position of body flexion of 60°, and knee and hip flexion of 90° and athletes were asked to keep the position as long as possible. To evaluate the general core muscle power, young athletes were asked to lie prone and lift their body on forearm and toes and keep the position as long as possible. For the lateral core muscle endurance athletes were asked to get into left and right decubitus position respectively and lift their body on forearm and toes and keep the position as long as possible. All tests were performed by a chronometer and test was terminated as the position was lost and the time passed was recorded

    Time frame: June 2021- August 2021

  2. Jamar hand dynamometer

    Hand grip strength was measured by Jamar hand dynamometer. Measurement was taken three times for both right and left sides while the subject was sitting on a chair, shoulder in adduction and elbow at 90 degree flexion. Twenty seconds of rest was given between the two measurements. Mean value of three results were calculated and recorded as kPa

    Time frame: June 2021- August 2021

  3. Upper Extremity Functional Performance

    Health ball throwing test was used to evaluate upper extremity open kinetic chain and explosive power. Subjects were told to hold the 3 kg health ball and throw it horizontally to the furthest possible point using two hands. The distance between the starting point and the first contact point on the floor was recorded as centimeters. Test was repeated three times and mean values were recorded.

    Time frame: June 2021- August 2021

  4. Reaction Time

    Reaction time and dynamic postural control was evaluated with ''Fitlight TrainerTM'' (Fitlight Trainer Corporation, Thensvej, Risskov, Denmark). Athletes were asked to turn out the LED lights placed on the wall that were randomly turned on and the total number of the LED lights they turned off and their reaction time were noted as seconds

    Time frame: June 2021- August 2021

  5. Agility Performance

    Agility test was used to evaluate the agility. Markers were placed at the left and right side 5 yard (4,57 m.) away from the starting point. Photocell gate was placed at the starting point to detect the passing times of the athletes. Athletes took position at the starting point and they were told to touch the right marker and then the left marker and turn back to starting point

    Time frame: June 2021- August 2021

  6. 3 Minutes Step Test

    A step board with the height of 30 cm., oxygen saturation probe, pulse oximeter, metronome and chronometer were used for the test. Athletes were informed about the test and rhythm of the metronome was delivered for certain time to get used to the rhythm. Athletes started the test with the foot they preferred and were asked to step on and off the board in harmony with the rhythm of the metronome. Oxygen saturation, pulse rates and Modified Borg Scale score that is used to identify fatigue were recorded at the end of the test

    Time frame: June 2021- August 2021

07

Study locations

1 site
  • Atılım University
    Ankara, Turkey
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 6, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05298839
Lead sponsor
Atılım University
Responsible party
Sponsor
First posted
Mar 28, 2022
Start date
Jun 1, 2021
Primary completion
Aug 30, 2021
Completion
Aug 30, 2021
Last update
Apr 6, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion